Symbiotec Pharmalab Limited (SYMBIOTEC) Price & Analysis

― Followers

SYMBIOTEC Stock Chart & Stats

1168.30

-31.00(-2.58%)

Oct 05, 2026

―

Day’s Range― - ―

52-Week Range933.80 - 1,245.65

Previous CloseN/A

VolumeN/A

Average Volume (3M)297.32K

Market Cap

₹77.06B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-10.36

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding64,256,110

10 Day Avg. Volume134,972

30 Day Avg. Volume297,317

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Symbiotec Pharmalab Limited News

Symbiotec’s Knovea inks U.S. DCV commercialization pact with global pharma major

Symbiotec Pharmalab Limited ( ($IN:SYMBIOTEC) ) just unveiled an announcement. Knovea Pharmaceutical, the wholly owned subsidiary of Symbiotec...

7d ago

Symbiotec Gets U.S. FDA EIR With VAI Rating for Pithampur Plant

The latest announcement is out from Symbiotec Pharmalab Limited ( ($IN:SYMBIOTEC) ). Symbiotec Pharmalab Limited has received an...

8d ago

SYMBIOTEC FAQ

What was Symbiotec Pharmalab Limited’s price range in the past 12 months?

Symbiotec Pharmalab Limited lowest stock price was 933.80 and its highest was 1245.65 in the past 12 months.

What is Symbiotec Pharmalab Limited’s market cap?

Symbiotec Pharmalab Limited’s market cap is ₹77.06B.

When is Symbiotec Pharmalab Limited’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Symbiotec Pharmalab Limited’s earnings last quarter?

Currently, no data Available

Is Symbiotec Pharmalab Limited overvalued?

According to Wall Street analysts Symbiotec Pharmalab Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Symbiotec Pharmalab Limited pay dividends?

Symbiotec Pharmalab Limited does not currently pay dividends.

What is Symbiotec Pharmalab Limited’s EPS estimate?

Symbiotec Pharmalab Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Symbiotec Pharmalab Limited have?

Symbiotec Pharmalab Limited has 64,256,110 shares outstanding.

What happened to Symbiotec Pharmalab Limited’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Symbiotec Pharmalab Limited?

Currently, no hedge funds are holding shares in IN:SYMBIOTEC

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology